FDA rejects psychedelic MDMA as treatment for PTSD
MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.
By Matthew Perrone
Latest ""
Veterans push for psychedelic therapy, but MDMA application struggles
Veterans have spent years lobbying for the use of psychedelic drugs to treat PTSD, but a critical review of MDMA has put the therapy's approval in doubt.
By Matthew Perrone
Opinion
MDMA-assisted therapy could save veterans and families. Like mine.
Our guest opinion writer, a military spouse, argues that the U.S. government should allow the use of MDMA to treat post-traumatic stress disorder.
By Elaine Brewer
FDA advisory panel votes against psychedelic therapy to treat PTSD
Panelists said they believe MDMA-assisted therapy is effective, but outstanding questions gave them pause in recommending its use to treat PTSD.
By Zamone Perez
Psychedelic to receive fast-track review as possible PTSD drug
The FDA wants to conclude its evaluation of MDMA-assisted therapy by Aug. 11.
By Zamone Perez
Why troops should be wary of blue lotus when using vapes, e-cigarettes
Five service members were treated by emergency services for complications arising from the use of Blue Lotus.
By Sarah Sicard